1999
DOI: 10.1016/s0939-6411(98)00089-7
|View full text |Cite
|
Sign up to set email alerts
|

Lauroyldextran and crosslinked galactomannan as coating materials for site-specific drug delivery to the colon

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(11 citation statements)
references
References 9 publications
0
11
0
Order By: Relevance
“…However, mechanical instability of the films was observed, especially at higher coating quantities, thereby suggesting their non-suitability for application in colonic carrier production. [106]…”
Section: Biopharmaceutical Applications Of Locust Bean Gummentioning
confidence: 99%
“…However, mechanical instability of the films was observed, especially at higher coating quantities, thereby suggesting their non-suitability for application in colonic carrier production. [106]…”
Section: Biopharmaceutical Applications Of Locust Bean Gummentioning
confidence: 99%
“…75 Theophylline biconcave tablets (9 mm-cores with 100 mg of theophylline and excipients) were coated with a Hüttlin Kugel coater having coatings of 4-17 mg/cm 2 . Sprayable coating formulations were obtained with 4% aqueous dispersions of crosslinked galactomannan in a 1:1 mixture of 1-propanol and water.…”
Section: Film Coatingmentioning
confidence: 99%
“…Bauer and Kesselhut (1995) synthesized dextran fatty acid ester and showed that lauroyl dextran esters with molecular weight of approximately 250,000 and degree of substitution ranging from 0.11 to 0.3 were suitable for colon targeted drug delivery as film coatings. In vitro studies with lauroyl dextrans esters bearing theophylline were carried out and Hirsch et al (1997) showed that addition of dextranase accelerated the drug release. However, further studies negated the utility of dispersion of lauroyl dextrans as coating material as they did not exhibit ideal zero-order dissolution before and quick disintegration after enzyme addition (Hirsch et al 1999).…”
Section: Dextransmentioning
confidence: 99%
“…In vitro studies with lauroyl dextrans esters bearing theophylline were carried out and Hirsch et al (1997) showed that addition of dextranase accelerated the drug release. However, further studies negated the utility of dispersion of lauroyl dextrans as coating material as they did not exhibit ideal zero-order dissolution before and quick disintegration after enzyme addition (Hirsch et al 1999). The dextran capsules appear to be excellent candidates for colon-specific drug delivery of almost any drug molecules as the polymer composition governs the specific release pattern (Bronsted, Andersen, and Hovgaard 1998).…”
Section: Dextransmentioning
confidence: 99%